Home » Topics » Regulatory » Patents

Patents
RSS

Novel iNOS inhibitors developed by Nippon Kayaku

May 4, 1998

Bayer's potassium channel ligands for cognition disorders

May 4, 1998

Pfizer synthesizes dual ORL1 antagonists/opioid receptor agonists

May 4, 1998

Lymphocyte-stimulating factor and methods of treating or preventing African sleeping sickness

May 1, 1998

Taisho scientists isolate cell adhesion inhibitors for arthritis, inflammation and asthma

May 1, 1998

Potent calpain inhibitors disclosed by Mitsubishi Chem.

May 1, 1998

European patents issued to Lilly for new benzothiophene compounds

May 1, 1998

Naturally occurring inhibitors of ICAM-1-mediated cell adhesion discovered by Taisho

April 30, 1998

CETP inhibitors for lipoprotein disorders discovered at Bayer

April 30, 1998

Gilead prepares orally active prodrugs of PMPA

April 30, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.